Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1986 1
1988 1
1993 1
1996 2
1997 1
2000 1
2007 1
2008 1
2009 1
2012 2
2015 3
2016 1
2017 2
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
[Neo-adjuvant chemotherapy].
Bumma C, Perroni D, Grecchi GL, Lauria G, Pautasso M. Bumma C, et al. Among authors: perroni d. Minerva Chir. 1988 Sep 30;43(18 Suppl):55-8. Minerva Chir. 1988. PMID: 3067122 Review. Italian. No abstract available.
High-resolution structures of a heterochiral coiled coil.
Mortenson DE, Steinkruger JD, Kreitler DF, Perroni DV, Sorenson GP, Huang L, Mittal R, Yun HG, Travis BR, Mahanthappa MK, Forest KT, Gellman SH. Mortenson DE, et al. Among authors: perroni dv. Proc Natl Acad Sci U S A. 2015 Oct 27;112(43):13144-9. doi: 10.1073/pnas.1507918112. Epub 2015 Oct 12. Proc Natl Acad Sci U S A. 2015. PMID: 26460035 Free PMC article.
Water Dynamics in Gyroid Phases of Self-Assembled Gemini Surfactants.
Roy S, Skoff D, Perroni DV, Mondal J, Yethiraj A, Mahanthappa MK, Zanni MT, Skinner JL. Roy S, et al. Among authors: perroni dv. J Am Chem Soc. 2016 Mar 2;138(8):2472-5. doi: 10.1021/jacs.5b12370. Epub 2016 Feb 19. J Am Chem Soc. 2016. PMID: 26875689
Phase III randomized multicenter study on the effects of adjuvant CMF in patients with node-negative, rapidly proliferating breast cancer: twelve-year results and retrospective subgroup analysis.
Amadori D, Nanni O, Volpi A, Casadei Giunchi D, Marangolo M, Livi L, Ravaioli A, Rossi AP, Gambi A, Luzi Fedeli S, Perroni D, Scarpi E, Becciolini A, Silvestrini R. Amadori D, et al. Among authors: perroni d. Breast Cancer Res Treat. 2008 Mar;108(2):259-64. doi: 10.1007/s10549-007-9593-9. Epub 2007 May 26. Breast Cancer Res Treat. 2008. PMID: 17530429 Clinical Trial.
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial.
De Placido S, Gallo C, De Laurentiis M, Bisagni G, Arpino G, Sarobba MG, Riccardi F, Russo A, Del Mastro L, Cogoni AA, Cognetti F, Gori S, Foglietta J, Frassoldati A, Amoroso D, Laudadio L, Moscetti L, Montemurro F, Verusio C, Bernardo A, Lorusso V, Gravina A, Moretti G, Lauria R, Lai A, Mocerino C, Rizzo S, Nuzzo F, Carlini P, Perrone F; GIM Investigators. De Placido S, et al. Lancet Oncol. 2018 Apr;19(4):474-485. doi: 10.1016/S1470-2045(18)30116-5. Epub 2018 Feb 23. Lancet Oncol. 2018. PMID: 29482983 Clinical Trial.
19 results